The antifungal drug miconazole was reported to induce both apoptotic and necroptotic cell death in human MDA-MB-231 breast cancer cells via augmented Bax/Bcl-2 ratio, upregulation of RIPK3 and MLKL phosphorylation levels, and ROS generation [288]. Here, RIPK3 is linked to breast cancer.